Givinostat for treating Duchenne muscular dystrophy in people 6 years and over [ID6323]
In development
Reference number: GID-TA11373
Expected publication date: TBC
Please note that following on from a request received from the company, the timelines for this appraisal have been revised. The deadline for submissions is expected in approximately early December 2024.
These timings are based on a request from the company to reschedule the initial date set by NICE, in order to facilitate a suitably comprehensive and robust submission.